Module D: Post-Patent Outlook - Rise of the Generics

14:15 – 14:50
Preparing for a post-patent world: What new strategies can Big Pharma employ to protect profitability for the future?
• Mergers and Acquisitions Is the market consolidating as quickly as anticipated?
• Effectively using emerging markets as long-term growth strategy - what are the real cost savings?
• Evaluating new ideas for production processes - how far can the industry innovate?
• External vs. internal innovation: How to create a sustainable sourcing strategy without becoming too dependent on externals (contractors, licensors, etc.)
• What is the optimum ratio for outsourcing activity?  What is too much?

14:50 – 15:30
Creating a successful generics portfolio: Identifying market opportunities and achieving differentiation
• What therapeutic areas are seeing the most growth in generics?  Where are the opportunities?
• How to avoid cannibalization of market share
• Knowing your market: Forecast of health care system changes and amendments across EU and US
• Cost of compliance, why small mistakes may lead to huge losses
• Are incentives working in countries where generic prescription is not compulsory?
Dr. Lori Shen, Director Global Strategic Sourcing, Pfizer

15:30 – 16:00
Defining the global market opportunity for Super Generics
• Exploring latest innovations in Super Generics
• Where are the market opportunities?
• How to successfully navigate regulatory approval in EU, US and Eastern countries
• Assessing the potential of Super Generics as a new low risk revenue stream
• Understanding the potential in shorter product development cycles, investment and ROI
• Identifying best outsourcing strategies to support research and production of Super Generics
 

Return to Agenda